2022

By the end of the congress, participants will be able to:

Discuss the results and practical implications of the latest clinical trials for the management of patients with type 1 and type 2 diabetes
Apply lifestyle and pharmacological approaches to the prevention and treatment of diabetes complications
Explain the latest guidelines and their implications for clinical practice
Describe the role of evidence-based medicine and how it applies to health care decision making

DAY 1: FRIDAY, APRIL 29
All times are set to Eastern Time
PLEASE NOTE: All sessions are IN PERSON and VIRTUAL, unless noted otherwise
9:00 am	Accredited Symposium: The Role Of Dual GIP/GLP-1 Receptor Agonism in Type 2 Diabetes
PLENARY SESSION #1
10:00 am	Welcome and Introductions	Zaina Albalawi, MD; Alanna Weisman, MD
10:10 am	Diabetes and Heart Failure: What must a diabetologist know?	Shelley Zieroth, MD
10:30 am	Obesity and Diabetes	Sean Wharton, MD
10:50 am	Decolonizing Diabetes Health Care	Randal Bell
11:10 am	Panel Discussion and Q & A	Shelley Zieroth, MD; Sean Wharton, MD; Randal Bell

11:35 am	IN PERSON: Health Break
12:00 pm	Accredited Symposium: Does My Patient With Shortness of Breath Have HfpEF?
PLENARY SESSION #2
1:05 pm	Update on Incretin Therapies	Alice Y.Y. Cheng, MD
1:25 pm	Nutrition and Diabetes	Michael Mindrum, MD
1:45 pm	Panel discussion and Q & A	Alice Y.Y. Cheng, MD; Michael Mindrum, MD

2:05 pm	IN PERSON: Health Break
PLENARY SESSION #3
2:30 pm	Diabetes and Mental Health	Barry Simon, MD
2:50 pm	Diabetes and Chronic Kidney Disease	David Cherney, MD
3:10 pm	Panel Discussion and Q & A	Barry Simon, MD; David Cherney, MD

3:30 pm	Accredited Symposium: Data Overload: Making Use of Continuous Glucose Data in Practice and Research
4:30 pm	IN PERSON EXCLUSIVE Keynote Presentation: Digital Models of Diabetes Care	Athena Phillis-Tsimikas, MD
4:50 pm	IN PERSON EXCLUSIVE Reception and Networking Event with Live Jazz Band
6:00 pm	End of Day 1

DAY 2: SATURDAY, APRIL 30
All times are set to Eastern Time
PLEASE NOTE: All sessions are IN PERSON and VIRTUAL, unless noted otherwise
9:00 am	Accredited Symposium: A Multidisciplinary Perspective on the Role of GLP-1RAs in Diabetes
PLENARY SESSION #4
10:00 am	Welcome and Introductions	Zaina Albalawi, MD; Alanna Weisman, MD
10:10 am	Fatty Liver Disease and NASH	Giada Sebastiani, MD
10:30 am	Technology Update	Alanna Weisman, MD
10:50 am	Exercise and Type 1 Diabetes	Jane Yardley, PhD
11:10 am	Panel discussion and Q & A	Giada Sebastiani, MD; Alanna Weisman, MD; Jane Yardley, PhD

11:35 am	IN PERSON: Health Break
12:00 pm	Accredited Symposium: Obesity Management in your Practice: Simple Recommendations to Improve Patient Care
PLENARY SESSION #5
1:05 pm	Update on Dyslipidemia	George Thanassoulis, MD
1:25 pm	Remission in Type 2 Diabetes	Zubin Punthakee, MD
1:45 pm	Panel Discussion and Q & A	George Thanassoulis, MD Zubin Punthakee, MD

2:05 pm	IN PERSON: Health Break
PLENARY SESSION #6
2:30 pm	Current and Future Approaches to Type 1 Diabetes: Beyond Insulin and Technology	Peter Senior, MD
2:50 pm	Debate: Use of SGLT2is in Hospital	Jacob A. Udell, MD; Shelley Zieroth, MD
3:30 pm	Panel Discussion and Q & A	Peter Senior, MD; Jacob A. Udell, MD; Shelley Zieroth, MD

3:50 pm	Closing Remarks	Zaina Albalawi, MD; Alanna Weisman, MD
4:00 pm	Congress End